By Emma Sykes, Science Policy Officer, Biochemical Society and the Royal Society of Biology
For our first Policy Lunchbox of the year we welcomed Naomi Weir, Deputy Director of the Campaign for Science and Engineering, CaSE, who led a highly animated discussion on the Government’s new Industrial Strategy and how we, the life science sector can make the most of it.
By Dorieke Grijseels, University of Sussex
February marks LGBT history month, a month in which we remember and celebrate lesbian, gay, bisexual, transgender history. It is great to see the lists of many important figures in LGBT history appearing on blogs and social media. As a scientist, one thing that strikes me, is that the lists rarely includes more than one or two scientists.
Continue reading Out and About STEM: Why visibility of LGBT scientists is important
By Sabrina Hossain, University of Birmingham
The progression of drug discovery and development over the last 50 years has been rather exciting for scientists and the community to follow. The drastic improvements of the techniques used to understand the molecular basis of diseases, alongside more competent machinery for a faster drug production line, has led to significant benefits for global health.
Continue reading Exploiting drug redeployment for modern-day drug discovery
By David Pye and Derry Mercer
On 20th November 2017, the EMA announced that it would be relocating to Amsterdam from London with the intention of commencing operations on 30th March 2019 at the latest. The choice of Amsterdam was no great surprise to anyone, except possibly for a few Milanese. The EMA, based in London since 1995, currently employs almost 900 staff and it is hoped that many will move with the EMA to their new headquarters taking with them their €322 million annual budget.
Continue reading European Medicines Agency and Brexit: Where next for the UK?
ARCHIVE 